Retrophin, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Retrophin, Inc..The latest application filed is for "biphenyl sulfonamide compounds for the treatment of kidney diseases or disorders".

Company Profile

9.15.14

Retrophin, Inc. - San Diego CA US
Retrophin, Inc. - New York NY US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Biphenyl Sulfonamide Compounds For The Treatment Of Kidney Diseases Or Disorders App 20210196688 - Komers; Radko ; et al.	2021-07-01
Biphenyl sulfonamide compounds for the treatment of kidney diseases or disorders Grant 10,864,197 - Komers , et al. December 15, 2	2020-12-15
Biphenyl Sulfonamide Compounds For The Treatment Of Kidney Diseases Or Disorders App 20200281901 - Komers; Radko ; et al.	2020-09-10
Biphenyl Sulfonamide Compounds For The Treatment Of Type Iv Collagen Diseases App 20200147050 - Komers; Radko ; et al.	2020-05-14
Solid Fosmetpantotenate Formulations App 20200121604 - Macikenas; Dainius ; et al.	2020-04-23
Pantetheine Derivatives For The Treatment Of Neurologic Disorders App 20190337971 - Beconi; Maria ; et al.	2019-11-07
Pantothenate derivatives for the treatment of neurological disorders Grant 10,407,447 - Vaino , et al. Sept	2019-09-10
Biphenyl Sulfonamide Compounds For The Treatment Of Kidney Diseases Or Disorders App 20190262317 - Komers; Radko ; et al.	2019-08-29
Cyclic phosphates and cyclic phosphoramidates for the treatment of neurologic disorders Grant 10,364,263 - Beconi , et al.	2019-07-30
Cyclic Phosphates And Cyclic Phosphoramidates For The Treatment Of Neurologic Disorders App 20180362564 - Beconi; Maria ; et al.	2018-12-20
Pantothenate Derivatives For The Treatment Of Neurological Disorders App 20180291045 - Vaino; Andrew ; et al.	2018-10-11
Pantothenate derivatives for the treatment of neurological disorders Grant 9,896,464 - Vaino , et al. February 20, 2	2018-02-20
Pantothenate derivatives for the treatment of neurologic disorders Grant 9,629,862 - Vaino , et al. April 25, 2	2017-04-25
Panothenate Derivatives For The Treatment Of Neurological Disorders App 20160264607 - Vaino; Andrew ; et al.	2016-09-15
Pantothenate Derivatives For The Treatment Of Neurologic Disorders App 20160015727 - Vaino; Andrew ; et al.	2016-01-21
Pantothenate derivatives for the treatment of neurologic disorders Grant 9,181,286 - Vaino , et al. November 10, 2	2015-11-10
Intranasal carbetocin formulations and methods for the treatment of autism Grant 9,023,793 - Leonard , et al. May 5, 2	2015-05-05
Pantothenate Derivatives For The Treatment Of Neurologic Disorders App 20140135294 - VAINO; Andrew ; et al.	2014-05-15
Pantothenate derivatives for the treatment of neurologic disorders Grant 8,673,883 - Vaino , et al. March 18, 2	2014-03-18
Pantothenate Derivatives For The Treatment Of Neurologic Disorders App 20130289001 - VAINO; Andrew ; et al.	2013-10-31

Company Registrations

NCAGE Code	77HN5	RETROPHIN, INC.
CAGE Code	77HN5	RETROPHIN, INC.
S.A.M. Registration	77HN5 [965454502]	RETROPHIN, INC.
SEC	0001438533	Retrophin, Inc. of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.